Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Results-Unaudited Financial Results For The Quarter Ended June 30, 2022

 Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)
05-08-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Results-Unaudited Financial Results For The Quarter Ended June 30, 2022

 Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)
05-08-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, August 5, 2022

 Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A) 2. Amended Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated persons and immediate relatives of Designated persons in the securities of the company as per Regulation 9 of SEBI (Prohibition of Insider Trading), Regulations, 2015; (Annexure B) 3. Amended Policy on Criteria for Determining Materiality of Events as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015 (Annexure C).
05-08-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2022(Q1)

 MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter ended June 30, 2022(Q1).
29-07-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as amended from time to time please find attached herewith the Compliance Certificate as received from 'Link Intime India Private Limited' Registrar and Share Transfer Agent of the Company for the quarter ended June 30, 2022..
11-07-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Intimation To Stock Exchange Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 ('LODR Regulations')

 The 'Company along with the other appellants' ('Appellants'), have challenged the order dated September 22 2020, passed by the Whole time member ('WTM') of Securities and Exchange Board of India SEBI (SEBI), before Securities Appellate Tribunal ('SAT'). In continuation of that, we wish to intimate that, an order was pronounced by the SAT. In terms of the order passed by the SAT, the impugned order passed by the SEBI against the Company cannot be sustained and hence quashed. The Copy of the SAT order is herewith attached for your reference. The Company is in the process of receiving the Certified Copy of the Order from the Registry.
02-07-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window

 In terms of provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code for prohibition of Insider Trading, the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (including their immediate relatives) from Friday, July 1, 2022 till the expiry of forty-eight (48) hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2022.
29-06-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 06, 2022 for Shree Kishoriju Trading & Investments Pvt Ltd
16-06-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions, for the period ended March 31, 2022. Kindly take the above information on your records.
06-06-2022
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 03, 2022 for Shree Kishoriju Trading and Investments Pvt Ltd
04-06-2022
Next Page
Close

Let's Open Free Demat Account